Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants

Clinical Infectious Diseases

Volumn 57, Issue 9, 2013, Pages 1368-1369

  Lipsitch, Marc ^a,b   Hernán, Miguel A ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Communicable Disease Dynamics   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTIBIOTIC THERAPY; ANTIBODY TITER; BIOLOGICAL ACTIVITY; CONVALESCENCE; HUMAN; INFECTION RISK; INFLUENZA; INTENTION TO TREAT ANALYSIS; LETTER; LOWER RESPIRATORY TRACT; LOWER RESPIRATORY TRACT COMPLICATION; LUNG COMPLICATION; META ANALYSIS (TOPIC); OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; THERAPY EFFECT;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BRONCHOPNEUMONIA; HUMANS; INCIDENCE; INFLUENZA, HUMAN; OSELTAMIVIR; PNEUMONIA, BACTERIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84886923361     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit481     Document Type: Letter

References (2)

1. Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: A meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53:277-9.
2. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2012; 1:CD008965. Available at: http://onlinelibrary.wiley. com/doi/10.1002/14651858.CD008965.pub3/abstract; jsessionid= DD3FA90D9957DE559ADC7471 E2275B4C.d03t01. Accessed 29 July 2013.